Put Options

6 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2022

Aug 16, 2022

SELL
$4.35 - $15.85 $81,780 - $297,980
-18,800 Closed
0 $0
Q1 2022

May 17, 2022

SELL
$4.55 - $6.41 $167,440 - $235,888
-36,800 Reduced 66.19%
18,800 $91,000
Q4 2021

Feb 15, 2022

SELL
$5.89 - $9.73 $993,643 - $1.64 Million
-168,700 Reduced 75.21%
55,600 $327,000
Q3 2021

Nov 16, 2021

SELL
$6.78 - $9.89 $400,020 - $583,510
-59,000 Reduced 20.83%
224,300 $1.91 Million
Q2 2021

Aug 16, 2021

BUY
$7.24 - $11.2 $878,936 - $1.36 Million
121,400 Added 74.98%
283,300 $2.29 Million
Q1 2021

May 18, 2021

BUY
$8.05 - $20.78 $1.3 Million - $3.36 Million
161,900 New
161,900 $1.74 Million

Others Institutions Holding VERU

About VERU INC.


  • Ticker VERU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,146,704
  • Market Cap $56.9M
  • Description
  • Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....
More about VERU
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.